移植診断の世界市場予測（～2021）：技術別（PCR、SSO-PCR、SSP-PCR、NGS、サンガーシーケンシング、マイクロアレイ）、製品＆サービス別、用途別、需要先別...市場調査レポートについてご紹介

1 Introduction (Page No. – 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 18)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Opportunity Indicators
2.2.1 Healthcare Expenditure Patterns
2.2.2 Rapid Growth in Geriatric Population
2.2.3 Rising Incidence and Prevalence of Cancer
2.2.4 Growing Burden of Cardiovascular Diseases
2.2.5 Organ Donations and Transplantations
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation

3 Executive Summary (Page No. – 36)

4 Premium Insights (Page No. – 41)
4.1 Global Transplant Diagnostics Market Overview
4.2 Global Transplant Diagnostic Technology Market, By Region (2016)
4.3 Global Transplant Diagnostics Product and Services Market, By Region (2016-2021)
4.4 Global Transplant Diagnostic Applications Market, By Region (2016-2021)
4.5 Global Transplant Diagnostic Market, By End User (2016–2021)

5 Market Overview (Page No. – 46)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Key Market Drivers
5.2.1.1 Rising Number of Solid Organ, Soft-Tissue, and Stem Cell Transplantation Procedures
5.2.1.2 Technological Advancements
5.2.1.3 Growing Public-Private Investments and Funding
5.2.1.4 Rising Incidence of Chronic and Infectious Diseases
5.2.2 Key Market Restraints
5.2.2.1 High Cost of NGS and PCR-Based Devices
5.2.2.2 Limited Medical Reimbursements for Organ Donation and Transplantation Procedures
5.2.3 Key Market Opportunities
5.2.3.1 Technological Shift From Serological Assays to Gene-Based Donor-Recipient Profiling
5.2.3.2 Untapped Opportunities in Emerging Markets
5.2.3.3 Increasing Public Awareness About Organ Donation and Transplantation in Developed Countries
5.2.4 Key Market Challenges
5.2.4.1 Significant Gap Between Number of Organs Donated and Organs Required Annually

6 Industry Insights (Page No. – 58)
6.1 Introduction
6.2 Value Chain Analysis
6.3 Industry Trends
6.3.1 Integration of Advanced Technologies With Molecular Assay Procedures
6.3.2 Development of Biomarkers for Transplantation Procedures
6.4 Porter’s Five Forces Analysis
6.4.1 Threat of New Entrants
6.4.2 Threat of Substitutes
6.4.3 Bargaining Power of Suppliers
6.4.4 Bargaining Power of Buyers
6.4.5 Intensity of Competitive Rivalry

7 Transplant Diagnostics Market, By Technology (Page No. – 64)
7.1 Introduction
7.2 Molecular Assay Technologies
7.2.1 PCR-Based Molecular Assay Technologies
7.2.1.1 Real-Time PCR
7.2.1.2 Sequence-Specific Primer-PCR (SSP-PCR)
7.2.1.3 Sequence-Specific Oligonucleotide-PCR (SSO-PCR)
7.2.1.4 Other PCR Technologies
7.2.2 Sequencing-Based Molecular Assay Technologies
7.2.2.1 Sanger Sequencing
7.2.2.2 Next-Generation Sequencing (NGS)
7.2.2.3 Other Sequencing Technologies
7.3 Non-Molecular Assay Technologies

8 Transplant Diagnostics Market, By Products & Services (Page No. – 79)
8.1 Introduction
8.2 Reagents and Consumables
8.3 Instruments
8.4 Software and Services

9 Transplant Diagnostics Market, By Application (Page No. – 85)
9.1 Introduction
9.2 Diagnostic Applications
9.2.1 Infectious Disease Diagnostics
9.2.2 Histocombatibility Testing
9.2.3 Blood Profiling
9.3 Research Applications

10 Transplant Diagnostics Market, By End User (Page No. – 93)
10.1 Introduction
10.2 Commercial Service Providers
10.3 Hospitals and Transplant Centers
10.4 Research Laboratories and Academic Institutes

11 Transplant Diagnostics Market, By Region (Page No. – 100)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.3 Europe
11.4 Asia-Pacific
11.5 Rest of the World (RoW)

12 Competitive Landscape (Page No. – 119)
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Scenario
12.3.1 Strategic Benchmarking
12.3.1.1 Pipeline Development and Product Commercialization
12.4 Recent Developments
12.4.1 New Product Launches, Approvals, and Product Enhancement
12.4.2 Agreements, Partnerships, and Collaborations
12.4.3 Acquisition
12.4.4 Expansion
12.4.5 Other Developments

13 Company Profiles (Page No. – 128)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 Introduction
13.2 Thermo Fisher Scientific Inc.
13.3 Bio-Rad Laboratories, Inc.
13.4 F. Hoffman-La Roche Limited
13.5 Qiagen N.V.
13.6 Immucor, Inc.
13.7 Biomérieux SA
13.8 Illumina, Inc.
13.9 Becton Dickinson and Company
13.10 Caredx, Inc.
13.11 Gendx

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. – 174)
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.4 Introducing RT: Real-Time Market Intelligence
14.5 Available Customizations
14.6 Related Reports